Reports and Briefs on Therapy Area

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Epidemiology of Hepatocellular Cancer in China

The size of HCC patient population in China provides a lucrative market for anti-cancer drugs. This epidemiologic analysis uses historical cancer incidence data to estimate and forecast HCC patient populations in China between 2012 and 2030.

Published By Datamonitor
25 Apr 2013 $2800
Buy
Report
Report

Hepatocellular cancer: Nexavar & Pipeline products

Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market

Published By Datamonitor
24 Apr 2013 $2000
Buy
Report
Report

The Hepatitis C Market Outlook to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
17 Apr 2013 $2800
Buy
Report
Report

The Inflammatory Bowel Disease Market Outlook to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
22 Mar 2013 $2800
Buy
Report
Report

The Vaccines Market Outlook to 2021

Strong growth expected in the vaccines market, as Sanofi Pasteur and Merck continue to dominate over the next 10 years.

Published By Datamonitor
13 Feb 2013 $2800
Buy
Report
Report

Product Profiles of Leading Vaccines

Changing recommendations and crowded immunization schedules continue to impact key vaccine brands.

Published By Datamonitor
13 Feb 2013 $2800
Buy
Report
Report

The Dyslipidemia Market Outlook to 2021

In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.

Published By Datamonitor
04 Feb 2013 $2800
Buy
Report
Report

The Market Outlook for Hepatitis C in China to 2021

The Chinese hepatitis C market will experience an increase in sales over the forecast period.

Published By Datamonitor
04 Feb 2013 $2800
Buy
Report
Report

Pipeline: Colorectal Cancer

Developers look to other molecular targets to avoid direct competition

Published By Datamonitor
01 Feb 2013 $2800
Buy
Report
Report

The Prostate Cancer Market Outlook to 2021

Recent approvals reinvigorate mCRPC market

Published By Datamonitor
18 Jan 2013 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.